thymalfasin is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2026-07-25. Numbers and descriptions here follow the published literature rather than marketing material.
Thymosin alpha-1 is a synthetic 28-amino-acid peptide whose sequence was first identified in extracts of bovine thymus tissue during the 1970s. The chain carries an acetyl group on its N-terminal serine. Its acidic residue content is high, which produces strong water solubility and an isoelectric point well below neutrality. Material supplied for laboratory and clinical use is manufactured by solid-phase peptide synthesis rather than purified from animal tissue. Different salt forms, such as the acetate, alter the counter-ion content without changing the peptide backbone.
Whether the free 28-residue peptide circulates in human tissue remains debated. The best-documented human source is prothymosin alpha, a larger acidic protein that carries the sequence at its N-terminus. Reports of measurable peptide levels in serum and lymphoid tissue exist, yet some of that signal may come from cross-reacting fragments or from the parent protein. Most reviews therefore treat prothymosin alpha as the established human molecule and describe independent circulation of the small peptide as an unresolved question.
Immunological studies connect the peptide to multiple parts of the immune response. It has been reported to engage Toll-like receptor signaling, to promote dendritic cell maturation, and to influence the balance of T helper cell subsets. Changes in natural killer cell activity and in cytokine release appear in cell culture and animal models. These observations describe broad immunomodulatory behavior rather than a single defined receptor target, and the primary molecular interaction has not been settled.
20世纪70年代，研究者从胸腺提取物中纯化出多种小肽，Tα1是其中被较早表征的一种。最初的制备依赖组织匀浆和层析步骤，产量低且成分复杂。随着固相肽合成技术成熟，实验室和工业界能够生产与天然序列一致的合成版本。合成肽的纯度可达95%以上，并可通过反相高效液相色谱和质谱进行鉴定。这一转变使研究不再依赖动物胸腺来源。
市售的胸腺素α1通常以冻干粉形式提供，溶解后用于注射。其氨基酸组成包括多个酸性残基，因此在中性pH下带负电荷。该肽可溶于水和生理盐水，但在有机溶剂中溶解度有限。储存条件通常为冻干状态下负20摄氏度，溶解后需冷藏并避免反复冻融。常见的同义词包括胸腺肽α1、thymalfasin和Tα1。
| Property | Value | Notes |
|---|---|---|
| Amino acid length | 28 residues | Single chain with an acetylated N-terminus |
| Molecular mass | Approximately 3,108 Da | Small shifts occur with counter-ion and water content |
| Isoelectric point | Around 3.5 | Low value follows from the many acidic residues |
| Parent molecule | N-terminal region of prothymosin alpha | Free circulating form in humans is not firmly established |
| Common synonyms | Thymalfasin; T alpha 1 | Older literature also uses the full spelled-out form |
Overall evidence quality varies considerably. A large share of published reports come from single centers, rely on surrogate immunological markers, or lack adequate control groups. Systematic reviews have highlighted this heterogeneity as a barrier to pooling results. Open questions include which patients, if any, might benefit, what treatment duration is appropriate, and whether any effect is independent of standard care. The peptide is often described as an immune modulator rather than a therapy for one disease, which complicates confirmatory trial design.
Thymosin alpha 1 was identified in 1977 as a component of thymosin fraction 5, a heterogeneous preparation used in early studies of thymic function. Investigators purified the active material and determined its amino acid sequence, which enabled chemical synthesis. Work in the following decades concentrated on T-cell maturation and immune reconstitution in animals and small human cohorts. Early preparations varied in composition, so results from that period are difficult to compare with studies using defined synthetic peptide.
Clinical research has examined the peptide in chronic hepatitis B and C, as a vaccine adjuvant, and in sepsis and oncology settings. Findings across trials are mixed; some report changes in selected immune markers, while others find no clear clinical benefit. Many studies are small and define outcomes differently, which limits comparison. Regulatory approval is confined to a few countries, and the compound is not an approved drug in the United States or most of Europe.
The peptide is generated in cells by cleavage of prothymosin alpha, a larger acidic protein encoded by the PTMA gene. Prothymosin alpha is expressed in many tissues, not only in the thymus, and its functions include nuclear roles in chromatin-related processes. The 28-residue fragment corresponds to the N-terminal portion of that precursor. How the cleavage occurs and how the fragment's concentration is regulated remain open questions; circulating amounts are small and difficult to measure reliably with routine assays.
Thymosin alpha 1 is a short peptide first isolated from bovine thymus tissue in the early 1970s during fractionation work aimed at identifying factors that influence T cell development. It belongs to a family of acidic thymic peptides, and the original preparations contained several components that were later separated by chromatography. The compound is now produced synthetically rather than extracted from tissue, which removes batch variability tied to animal sourcing. Researchers describe it as an immunomodulatory peptide because laboratory studies show effects on several cell types of the innate and adaptive immune systems.
Early work on thymic extracts in the 1960s described a heat-stable acidic fraction containing many polypeptides. Separation of that mixture yielded individual components, and thymosin alpha-1 was named as one of them on the basis of assays for T-cell activity. The first preparations came from calf thymus, while subsequent research and clinical material has been chemically synthesized. Nomenclature in older papers is inconsistent, and the same peptide sometimes appears under different designations, which complicates literature searches.
Most published studies on thymosin alpha-1 report changes in immune measurements rather than clinical outcomes, and findings differ across designs and populations. Whether the peptide signals through one defined receptor or through several less specific interactions remains an open question. Its reported circulation half-life of a few hours complicates comparison of dosing schedules across trials. Mechanistic claims are frequently drawn from isolated cell cultures, and how far those results extend to whole organisms is unresolved.
Thymosin alpha-1 is a synthetic peptide of 28 amino acids whose sequence matches the amino-terminal region of prothymosin alpha. The chain is acetylated at its first residue and contains one disulfide bridge between two cysteine residues, which folds the molecule into a compact loop. Its molecular formula, C129H215N33O55, corresponds to a monoisotopic mass of roughly 3,106 daltons. Material used in laboratories is made by solid-phase synthesis rather than isolated from animal tissue.
=== IgE-independent activation === The most versatile IgE-independent receptor is known as MrgprB2 in mice and MRGPRX2 in humans. These receptors can recognize many different, mostly positively charged compounds. MrgprB2 is expressed in connective tissue mast cells but not in mucosal mast cells of mice. Binding of ligands to MrgprB2 results in activation of G-protein-signaling pathways.
Liver or kidney failure – Lorazepam may be safer than most benzodiazepines in people with impaired liver function. Like oxazepam, it does not require liver oxidation, but only liver glucuronidation into lorazepam-glucuronide. Therefore, impaired liver function is unlikely to result in lorazepam accumulation to an extent causing adverse reactions. Similarly kidney disease has minimal effects on lorazepam levels. Drug and alcohol dependence – The risk of abuse of lorazepam is increased in dependent people. Comorbid psychiatric disorders also increase the risk of dependence and paradoxical adverse effects.
Akram Elias is a businessman from Lebanon living in Washington, D.C., who was the founder and CEO of a private consulting firm in the city called Capital Communications Group. Elias was initiated as a Freemason in 1996, and by 2008 was the Most Worshipful Brother (former Master) of Potomac Lodge No. 5, but had also been raised into stature within the Grand Lodge of Masonic Education and the Grand Lodge of Washington, D. C. The first time he toured Cuba was in 2001, and he made several trips over the years. On one of those trips, in 2004, he personally met Grand Master Collera Venta to discuss Freemasonry in America (e.g., the Americas), and the future of Cuban Freemasonry. In 2004, Alan Gross, a Maryland man from DAI Global, a subcontracting company for USAID, carried a package of electronics equipment and money to Cuba for Marc Wachtenheim. Gross didn't know any Spanish, and was not an expert on Cuba. Gross delivered this package to Grand Master Collera Venta. Gross made five trips to the island between 2004 and 2009, smuggling communications equipment to Collera Venta every time. Certain items that Alan Gross carried into Cuba were BGAN satellite internet links into Jewish communities to circumvent the Cuban firewall. Gross also reached out to Jewish American humanitarian organizations like the Jewish Federations of North America and their chapter in Broward County, Florida, to smuggle contraband items into Jewish communities in Cuba to allow them to communicate to the outside world.
=== Wound occlusion === Many animals are able to block off the area around an injury rapidly, by coagulating their blood or body fluid. Invertebrates with hydrostatic skeletons (moving by peristalsis) are unable to move without internal fluid under pressure, while those with an open circulation (body fluid not confined to blood vessels) quickly die from loss of body fluid. In addition, open wounds allow bacteria to enter the body. The invertebrate coagulation system is comparable with the innate immune system (the simpler of two systems of protection against infection) of vertebrates.
Sources: en.wikipedia.org
=== April === 2 April – The Birmingham Walkathon returns to the city for the first time since 2013. The event, originally organised by Birmingham radio station BRMB, is organised for its 2023 staging by former BRMB director David Bagley and charity Help Harry Help Others. 3 April – NHS England launches its spring booster campaign, which will see around five million people, including those aged over 75 or classed as clinically vulnerable, receive a COVID-19 booster vaccine. The National Education Union announces two further strike dates in England on 27 April and 2 May, stating that the offer from the pay UK government is unacceptable, not fully funded, and does not address a shortage of teachers. Environment Minister Therese Coffey confirms government plans to ban wet wipes containing plastic in England as a means of helping to tackle water pollution. The new England women's national football team kit is unveiled, and it is confirmed they will wear blue shorts at the 2023 World Cup. The change has been made amid period concerns. 4 April – Members of the Association of School and College Leaders overwhelmingly reject the UK government's 4.3% pay offer for teachers in England. 5 April – Twenty one people are convicted over the largest child sex abuse case ever investigated by West Midlands Police. The National Association of Head Teachers becomes the third teaching union to reject the UK government's 4.3% pay offer for teachers in England.
=== Oxidative stress === Many algicides produced by bacteria increase reactive oxygen species (ROS), which are highly reactive molecules produced during cell processes such as photosynthesis and respiration inside algal cells. This damages DNA, proteins, and lipids, due to an oxidative chain reaction which produces toxic products that lead to cell death. Algal cells can usually counteract these elevated ROS levels with antioxidants, however excessive or prolonged ROS levels can overwhelm the cell and lead to its death. Oxidative stress can be detected in algae based on elevated levels of malondialdehyde (MDA), which is a marker of lipid peroxidation (where lipids are attacked by oxidants), as well as elevated levels of antioxidants and defence enzymes.
== Musical style == Chuquimamani-Condori's music is notable for drawing from an eclectic and wide variety of influences, including cumbia, and Andean music like huayno and tarqueada, as well as American genres like crunk, metal, ambient, R&B and minimalism. However, their eclecticism is owed to their understanding and incorporation of Aymara ontology in their music, specifically the concepts of taypi and ch'ixi. As a way of summing up their stylistic intent, they have used the tags prog and folk to describe their music. During the time of the making of their album American Drift, they were living in rural Virginia and being inspired by the expansive local geographical features around the area, described as "wild Southern surroundings", in the area, one of which was the Shenandoah Mountain. They previously made journeys around it, with one inspiring track two of American Drift, 'Petrichrist'. They are heavily inspired by varying forms of cultural music and the interesting sound design that often accompanies them, although their upbringing and roots in music that have influenced their show their presence. In an interview, they remarked that "the older I get, the uglier I want my music to feel, to be".
== Endogenous toxins == Endogenous reactive metabolites, such as peroxides, reactive oxygen species and reactive aldehydes, arise continuously from normal cellular metabolism and can damage proteins, lipids and nucleic acids if not controlled. Their detoxification involves both broad-spectrum and specialized enzymatic systems, including families that act on reactive carbonyls and other electrophiles, as well as dedicated pathways for particularly toxic intermediates. The glyoxalase system, consisting of glyoxalase I and II, uses glutathione to convert the reactive dicarbonyl methylglyoxal, a by-product of glycolysis, into D‑lactate. Antioxidant defence systems, including superoxide dismutases, catalase, peroxiredoxins and glutathione peroxidases, convert reactive oxygen species such as superoxide and hydrogen peroxide into less reactive products, and low-molecular-mass antioxidants such as glutathione, ascorbate and tocopherols further limit oxidative chain reactions. Together, these mechanisms maintain redox homeostasis and restrict the toxic effects of endogenous reactive metabolites.
=== α2-Adrenergic receptor agonists === α2-Adrenergic receptor agonists like clonidine can improve sleep and may be useful in the treatment of insomnia. An example of this is in the treatment of insomnia in children and adolescents with attention deficit hyperactivity disorder (ADHD), for instance due stimulant therapy. Similarly to clonidine, the α2-adrenergic receptor agonist dexmedetomidine has sedative and hypnotic effects and is used to produce sedation in hospital settings. The sleep induced by dexmedetomidine is said to closely resemble natural sleep. The selective α2A-adrenergic receptor agonist tasipimidine (ODM-105) is under development for the treatment of insomnia and is in phase 2 clinical trials for this indication as of October 2024. α2-Adrenergic receptor agonists can produce hypotension and bradycardia as side effects, which has limited their use. Activation of the α2A-adrenergic receptor is thought to be responsible for most of the physiological effects of the α2-adrenergic receptors, including hypotension. On the other hand, the preferential α2A-adrenergic receptor agonist guanfacine appears to show less sedation and hypotension than clonidine. Tizanidine has been used off-label for sleep similarly to clonidine, but likewise shows less hypotensive potency in comparison.
Sources: en.wikipedia.org
It is usually described as an immunomodulatory peptide rather than a classic circulating hormone. No endocrine gland is known to release it as a primary secretory product, and its measured presence in blood is not firmly established.
Prothymosin alpha is a much larger acidic protein, roughly 111 to 113 residues long, and the thymosin alpha-1 sequence matches its N-terminal region. The small peptide is therefore best understood as a fragment of that parent protein rather than a separate gene product.
Trials and clinical reports have examined chronic hepatitis B and C, use as a vaccine adjuvant, and supportive treatment in some immunodeficiency and oncology settings. Results vary by indication, and regulatory approval differs between countries.
它不是经典的内分泌激素，而是一种免疫调节肽。其作用主要通过局部免疫细胞间的信号传递实现，而非经血液循环作用于远隔器官。